학술논문
Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide
Document Type
Academic Journal
Author
Source
ejHaem. November 2023, Vol. 4 Issue 4, p1212, 4 p.
Subject
Language
English
Abstract
Myelodysplastic neoplasms (MDS) are clonal myeloid neoplasms with an increased risk of progression to acute myeloid leukemia (AML). For patients unfit for hematopoietic cell transplantation (HCT), hypomethylating agents, such as [...]